Drug Research
NHS To Deploy Variant-Busting Booster Jab Ahead of Winter
The NHS has now laid out plans for the next stage of the COVID-19 vaccination effort, the biggest and most rapid vaccine drive in the history of the health service, in response to the updated guidelines outlined by the...
Drug Research
Priority Review of Lynparza If Paired With Abiraterone In US
Priority consideration has been given to AstraZeneca's supplemental new drug application for Lynparza (olaparib) when used in conjunction with abiraterone, prednisone, or prednisolone to treat elderly patients with advanced castration-resistant prostate cancer (mCRPC).
AstraZeneca and MSD, also known as Merck...
Drug Research
Trends of Genuv Cancer Drug Show Potential For Alzheimers
Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective impact on Alzheimer's disease, according to Genuv Inc. of South Korea, which has announced the...
Drug Research
Axsome Pitches Auvelity As A Depression Med Game-Changer
It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with MDD diagnoses and the unmet demand.
In light of this, the time is right for the...
Drug Research
Gene Therapy By Bluebird Bio Costing $2.8M Given Nod By FDA
Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US.
Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was authorised by the FDA on August 17, two days before the FDA's scheduled approval action...
Drug Research
ADCs Built On Starpharma Delivery Tech To Be Tested By Merck
As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will allow it to assess potential candidates using a dendrimer drug delivery technology.
Merck and Starpharma agreed...
Drug Research
After Roe, Bayer Engages Lobbyists For Contraception Access
While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push of its own.
A disclosure form reveals that Bayer has hired a team of lobbyists to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read